Comparison of antigen expression from plasmid DNA in tumor-free and antigen-expressing tumor-bearing mice

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 2, 2012, Pages 184-190

  Guan, Xin ^a   Nishikawa, Makiya ^a   Li, Hisoon ^a   Rei, Takahashi ^b   Takahashi, Yuki ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

Author keywords

Antigen specific immune response; Cancer; Gene delivery; Gene therapy; Genetic vaccination; Ovalbumin; Plasmid DNA

Indexed keywords

DNA VACCINE; FIREFLY LUCIFERASE; OVALBUMIN; PLASMID DNA; LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HUMORAL IMMUNITY; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; SINGLE DRUG DOSE; T CELL LYMPHOMA; CANCER GENE THERAPY; CYTOTOXIC T LYMPHOCYTE; DNA IMMUNIZATION; GENE EXPRESSION; LYMPHOCYTIC INFILTRATION; PROTEIN EXPRESSION; TRANSGENE;

ANIMALS; ANTIGENS, NEOPLASM; CYTOMEGALOVIRUS; FEMALE; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; OVALBUMIN; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 84861834999     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.9.2.18370     Document Type: Article

References (19)

1. Prud'homme GJ. DNA vaccination against tumors. J Gene Med 2005; 7:3-17; PMID:15538731; http://dx.doi.org/10.1002/jgm.669
2. Babiuk S, Baca-Estrada M, Babiuk LA, Ewen C, Foldvari M. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J Control Release 2000; 66:199-214; PMID:10742580; http://dx.doi.org/10.1016/S0168-3659(99)00274-6
3. Yamaoka A, Guan X, Takemoto S, Nishikawa M, Takakura Y. Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system. J Control Release 2010; 142:411-5; PMID:19913062; http://dx.doi.org/10.1016/j. jconrel.2009.11.005
4. Guan X, Nishikawa M, Takemoto S, Ohno Y, Yata T, Takakura Y. Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination. J Gene Med 2010; 12:301-9; PMID:20084616
5. Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 2007; 25:267-96; PMID:17134371; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141609
6. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21:685-711; PMID:12615891; http://dx.doi.org/10.146/annurev. immunol.21.120601.141040
7. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006; 6:295-307; PMID:16557261; http://dx.doi.org/10.1038/nri1806
8. Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 2005; 78:1043-51; PMID:16204623; http://dx.doi.org/10.1189/jlb.0705358
9. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA, et al. Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 2006; 24: 99-146; PMID:16551245; http://dx.doi.org/10.1146/annurev.immunol.24.021605. 090737
10. + regulatory T cells in antitumor immune response. J Immunol 2005; 175:4433-40; PMID:16177085
11. Melero I, Hervas-Stubbs S, Glennie M, Pardoll DM, Chen L. Immunostimulatory monoclonal antibodies for cancer therapy. Nat Rev Cancer 2007; 7:95-106; PMID:17251916; http://dx.doi.org/10.1038/nrc2051
12. Greenland JR, Letvin NL. Chemical adjuvants for plasmid DNA vaccines. Vaccine 2007; 25:3731-41; PMID:17350735; http://dx.doi.org/10.1016/j.vaccine. 2007.01.120
13. Zinkernagel RM, Hengartner H. Regulation of the immune response by antigen. Science 2001; 293:251-3; PMID:11452115; http://dx.doi.org/10.1126/ science.1063005
14. Kündig TM, Bachmann MF, Oehen S, Hoffmann UW, Simard JJ, Kalberer CP, et al. On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci USA 1996; 93:9716-23; PMID: 8790397; http://dx.doi.org/10.1073/ pnas.93.18.9716
15. Payette PJ, Weeratna RD, McCluskie MJ, Davis HL. Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms. Gene Ther 2001; 8:1395-400; PMID:11571579; http://dx.doi.org/10.1038/sj.gt.3301534
16. Strausberg RL. Tumor microenvironments, the immune system and cancer survival. Genome Biol 2005; 6:211; PMID:15774034; http://dx.doi.org/10.1186/gb- 2005-6-3-211
17. Thanaketpaisarn O, NishikawaM, Yamashita F, Hashida M. Tissue-specific characteristics of in vivo electric gene: transfer by tissue and intravenous injection of plasmid DNA. Pharm Res 2005; 22:883-91; PMID:15948032; http://dx.doi.org/10.1007/s11095-005-4583-2
18. Ke Y, Li Y, Kapp JA. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses. Eur J Immunol 1995; 25:549-53; PMID:7875219; http://dx.doi.org/10.1002/eji.1830250237
19. Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988; 54:777-85; PMID: 3261634; http://dx.doi.org/10.1016/S0092-8674(88) 91043-4